A medical device validation study is only as strong as the protocol guiding it. A well-designed protocol provides clear procedures, prespecified endpoints, consistent study conduct, and a structured framework for generating high-quality clinical data. Clinical trial protocol development is a critical component of successful medical device validation and helps ensure that study results are interpretable, traceable, and regulator-ready. Why Protocol Development Matters The p

Collecting clinical data is only one part of generating regulator-ready evidence. Regulatory reviewers expect clinical datasets that are accurate, traceable, complete, and supported by clearly documented methods and prespecified analysis procedures. Strong data quality practices help sponsors reduce review questions, support efficient regulatory assessment, and ensure study results can be interpreted with confidence. What Is a Regulator-Ready Dataset? A regulator-ready dat

Cuffless blood pressure technologies are transforming physiological monitoring by enabling continuous, wearable, and minimally intrusive measurement approaches. Validating these devices requires careful study design because traditional cuff-based reference techniques do not always match continuous or near-continuous outputs. For continuous non-invasive blood pressure systems, validation expectations are addressed by ISO 81060-3. Selecting the correct reference method is one